Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck

European Journal of Cancer ◽

10.1016/s0959-8049(01)00216-7 ◽

2001 ◽

Vol 37 (16) ◽

pp. 2015-2022 ◽

Author(s):

K.J Harrington ◽

C Lewanski ◽

A.D Northcote ◽

J Whittaker ◽

A.M Peters ◽

...

Keyword(s):

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Liposomal Doxorubicin ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Pegylated Liposomal Doxorubicin

Download Full-text

8546 POSTER A Phase II Study of Docetaxel, Cisplatin, and Oral S-1 Induction Chemotherapy Followed by Chemoradiotherapy in Advanced Squamous Cell Cancer of the Head and Neck – Preliminary Results: a Trial of the Korean South West Oncology Group

European Journal of Cancer ◽

10.1016/s0959-8049(11)72188-8 ◽

2011 ◽

Vol 47 ◽

pp. S557

Author(s):

W. Bae ◽

K. Kim ◽

Y. Joo ◽

I. Chung ◽

S. Cho ◽

...

Keyword(s):

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Oncology Group ◽

Preliminary Results ◽

Download Full-text

Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck

10.1186/1471-2407-13-102 ◽

2013 ◽

Vol 13 (1) ◽

Author(s):

Woo Kyun Bae ◽

Jun Eul Hwang ◽

Hyun Jeong Shim ◽

Sang Hee Cho ◽

Ki Hyeong Lee ◽

...

Keyword(s):

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Locally Advanced ◽

Weekly Docetaxel ◽

Multicenter Phase

Download Full-text

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck – the RESGEX study

ESMO Open ◽

10.1016/j.esmoop.2021.100242 ◽

2021 ◽

Vol 6 (5) ◽

pp. 100242

Author(s):

K. Klinghammer ◽

J. Fayette ◽

A. Kawecki ◽

A. Dietz ◽

P. Schafhausen ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Efficacy And Safety ◽

Randomized Phase Ii ◽

Download Full-text

A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058905 ◽

1994 ◽

Vol 5 (6) ◽

pp. 513-519 ◽

Author(s):

P. Pinnarò ◽

M.C. Cercato ◽

D. Giannarelli ◽

P. Carlini ◽

M.R. Del Vecchio ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Locally Advanced ◽

Randomized Phase Ii

Download Full-text

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

The Oncologist ◽

10.1634/theoncologist.2017-0069 ◽

2017 ◽

Vol 22 (7) ◽

pp. 782 ◽

Author(s):

Marco Siano ◽

Francesca Molinari ◽

Vittoria Martin ◽

Nicolas Mach ◽

Martin Früh ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Advanced Head ◽

Multicenter Phase ◽

Neck Squamous Cell Cancer

Download Full-text

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

European Journal of Cancer ◽

10.1016/s0959-8049(11)72175-x ◽

2011 ◽

Vol 47 ◽

pp. S553 ◽

Author(s):

E. Remenar ◽

J. Lövey ◽

P. Koltai ◽

K. Horvath ◽

M. Gödeny ◽

...

Keyword(s):

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Locally Advanced ◽

Download Full-text

A phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5532 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5532-5532 ◽

Author(s):

A. L. Sabichi ◽

M. S. Kies ◽

B. S. Glisson ◽

C. Lu ◽

L. E. Ginsberg ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Download Full-text

A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5554 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5554-5554

Author(s):

D. G. Pfister ◽

S. Haque ◽

H. Stambuk ◽

D. M. Lisa ◽

R. Shen ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Neck Squamous Cell Cancer

Download Full-text

A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m2for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2012.0144 ◽

2012 ◽

Vol 10 (11) ◽

pp. 1391-1398 ◽

Author(s):

Matthew G. Fury ◽

Eric Sherman ◽

Donna Lisa ◽

Neeraj Agarwal ◽

Kenneth Algazy ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Randomized Phase Ii ◽

Neck Squamous Cell Cancer

Download Full-text

632 POSTER Randomized phase II study of BMS-247550 (NSC 710428) given daily X 5 days or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: E2301

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)70637-1 ◽

2006 ◽

Vol 4 (12) ◽

pp. 190-191 ◽

Author(s):

B. Burtness ◽

J. Manola ◽

A. Argiris ◽

D. Altieri ◽

R. Axelrod ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Randomized Phase Ii

Download Full-text